glp 1 drugs for alcohol use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance disorders: An emerging pharmacotherapeutic target GLP-1 drugs linked to lower
Description
412 Notably, GLP-1RAs, including exendin-4, have been shown to attenuate microglial activation, resulting in a reduction in the expression of proinflammatory cytokines such as TNF- and IL-1
Reducing Addictive Drive and Preventing New Addictions GLP-1s appear to reduce addictive behaviors across multiple substances and compulsive activities
Citations Please use one of the following formats to cite this article in your essay, paper or report: APA Kumar Malesu, Vijay
This article breaks down the costs associated with GLP-1 drugs and what to consider
